Four IPOs each raised at least $75 million this week as the Fall IPO market continued to hum along, while one company ...

Indian equities have surged in recent years driven by strong macro environment, corporate earnings, and domestic equity ...

Check local perspective on a topic that doesn't have so much to do with medical need but the cost of doing biz in the urban ...

According to Insider Monkey’s data, 21 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) as of Q2, with a ...

But, for the first time, injecting epinephrine isn’t the only option. A San Diego-based company, ARS Pharmaceuticals, has ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of ...

Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...

PBMs are under the microscope for allegedly inflating drug prices. New Barron’s reporting raises broader questions about the ...

The pharmaceutical supply chain improves packaging, Hurricane Milton disrupts the perishable supply chain and caffeine comes in frozen form.

A former executive to a Novi pharmaceuticals wholesaler will serve one year and one day in prison for submitting false documentation for a bank loan, officials said. Theodore Toloff, 65, pleaded ...